Gene · 80320
SP6: Sp6 transcription factor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SP6: Sp6 transcription factor. Genes, record 80320. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/80320
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q3SY56 | Transcription factor Sp6 | 376 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents31
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2025147176 A | 2025-10-06 | 15679 | Q3SY56 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15679 | Q3SY56 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15679 | Q3SY56 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15518 | Q3SY56 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 82668 | Q3SY56 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 82669 | Q3SY56 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 185639 | Q3SY56 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 185640 | Q3SY56 | Espacenet |
| JP 2021536249 A | 2021-12-27 | 15872 | Q3SY56 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 10832 | Q3SY56 | Espacenet |
1 to 10 of 31
See all 31 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,305
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SP6 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 5 | 2025 |
| R01EY011500 | Structure-function studies of visual arrestin | 5 | 2025 |
| P30DK017047 | Diabetes Research Center | 3 | 2025 |
| P30EY008126 | Core Grant in Vision Research | 3 | 2025 |
| T32CA009302 | Leveraging innovative technologies in basic and clinical cancer research | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 2 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
1 to 10 of 1,305Source NIH's project files
See all 1,305 nih grantsPapers2,366
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nurse-Led SP6 and LI4 Acupressure for Improving Labour Pain, Maternal Coping, and Intrapartum Maternal Comfort: A Three-Arm Pilot Randomized Controlled Trial Guided by Swanson's Theory of Caring. | J Holist Nurs | 2026 | 42622803 | PubTator, text mining | PubMed |
| Intrapartum Acupuncture Provision in the UK: A Survey of Independent Acupuncture Practitioners. | Healthcare (Basel) | 2026 | 42588292 | PubTator, text mining | PubMed |
| Effects of SP6 Acupressure on Labor Pain During Childbirth Among Nulliparous Women: A Randomized Clinical Trial. | Iran J Nurs Midwifery Res | 2026 | 42466296 | PubTator, text mining | PubMed |
| The Lysis Genes of the Paradigm Phage SP6. | Phage (New Rochelle) | 2026 | 42130963 | PubTator, text mining | PubMed |
| Most Useful Acupuncture Points (MUAPs) Teaching Cluster: A Structured Narrative Review of Mechanistic Evidence for Biomedical Acupuncture Training. | Cureus | 2026 | 42099340 | PubTator, text mining | PubMed |
| Construction and validation of risk prediction model for glioblastoma associated with cancer stem cells and disulfidptosis. | Transl Cancer Res | 2026 | 41969489 | PubTator, text mining | PubMed |
| Core Acupoint Prescription Patterns for Primary Dysmenorrhea: Data Mining and Network-Based Analysis. | J Pain Res | 2026 | 41868293 | PubTator, text mining | PubMed |
| Bipolar CD4-targeted dual-DARPin-55/57 lipid nanoparticle enables efficient CRISPR/Cas-mediated HIV-1 DNA excision and reactivation blockade in latent CD4 T cell lines. | Mater Today Bio | 2026 | 41769381 | PubTator, text mining | PubMed |
| Effect of acupuncture pretreatment on clinical pregnancy rate in women with diminished ovarian reserve undergoing IVF-ET: study protocol for a multicenter randomized controlled trial. | Front Endocrinol (Lausanne) | 2026 | 41727691 | PubTator, text mining | PubMed |
| Biallelic DAW1 variants reveal tissue-specific role in heterotaxy without primary ciliary dyskinesia. | Res Sq | 2026 | 41727625 | PubTator, text mining | PubMed |
1 to 10 of 2,366
See all 2,366 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/80320
GET https://conductscience.org/api/genes/v1/80320/patents?page=2